{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:50:08Z","timestamp":1793717408618,"version":"4.6.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Cannabidiol (CBD) has gained significant attention for its potential therapeutic benefits, but its safety profile in healthy populations remains underexplored. This systematic review and meta-analysis aim to evaluate the safety of CBD compared to placebo in healthy adults. A comprehensive search of PubMed, Embase, Cochrane CENTRAL, and ClinicalTrials.gov identified four randomized controlled trials (RCTs) involving 269 healthy adults. The primary outcome was headache, with secondary outcomes including fatigue, abdominal pain, diarrhea, upper respiratory tract infection (URTI), and dizziness. The results revealed that CBD use was associated with a significantly higher risk of diarrhea (RR\u00a0=\u00a05.85; 95% CI\u00a0=\u00a01.14\u201330.02;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.03). While there was a trend toward increased abdominal pain and headache, these results were not statistically significant. Fatigue, dizziness, and URTI showed no significant differences between the CBD and placebo groups. These findings suggest that while CBD appears safe for short-term use in healthy adults, gastrointestinal side effects, particularly diarrhea, should be monitored. Further large-scale studies with longer follow-up periods are warranted to confirm these results and explore long-term safety.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000004549","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:08:14Z","timestamp":1770905294000},"page":"2348-2356","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Safety of cannabidiol versus placebo in healthy population: a systematic review and meta-analysis"],"prefix":"10.1097","volume":"88","author":[{"given":"FNU","family":"Sawaira","sequence":"first","affiliation":[{"name":"Khyber Girls Medical College, Peshawar, Khyber Pakhtunkhwa, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asim","family":"Shah","sequence":"additional","affiliation":[{"name":"Khyber Medical College, Peshawar, Khyber Pakhtunkhwa, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed W.","family":"Hageen","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maham","family":"Rashid","sequence":"additional","affiliation":[{"name":"Dow Medical College, Dow University of Health Sciences, Karachi, Sindh, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahat","family":"Ullah","sequence":"additional","affiliation":[{"name":"Gomal Medical College, Dera Ismail Khan, Khyber Pakhtunkhwa, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Eisa","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizaz","family":"Ali","sequence":"additional","affiliation":[{"name":"Khyber Teaching Hospital, Affiliated with Khyber Medical College, Peshawar, Khyber Pakhtunkhwa, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Younas","sequence":"additional","affiliation":[{"name":"Gomal Medical College, Dera Ismail Khan, Khyber Pakhtunkhwa, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassaan","family":"Qazi","sequence":"additional","affiliation":[{"name":"Bannu Medical College, Bannu, Khyber Pakhtunkhwa, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Owais","sequence":"additional","affiliation":[{"name":"Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, Sindh, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Yasir","sequence":"additional","affiliation":[{"name":"Bacha Khan Medical College, Mardan, Khyber Pakhtunkhwa, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husna Irfan","family":"Thalib","sequence":"additional","affiliation":[{"name":"Batterjee Medical College, Jeddah, Makkah Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazhar Ali","family":"Shah","sequence":"additional","affiliation":[{"name":"Khyber Medical College, Peshawar, Khyber Pakhtunkhwa, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8208-0689","authenticated-orcid":false,"given":"Kamil Ahmad","family":"Kamil","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Mirwais Regional Hospital, Kandahar, Afghanistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"R1-20260304","doi-asserted-by":"crossref","first-page":"2011\u201320","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"key":"R2-20260304","doi-asserted-by":"crossref","first-page":"825\u201336","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"key":"R3-20260304","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.3390\/molecules28165980","article-title":"Molecular and cellular mechanisms of action of cannabidiol","volume":"28","author":"Martinez Naya","year":"2023","journal-title":"Molecules"},{"key":"R5-20260304","first-page":"439\u201356","article-title":"A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)","volume":"130","author":"Peng","year":"2022","journal-title":"Basic Clin Pharmacal Toxicol"},{"key":"R6-20260304","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s42238-021-00061-5","article-title":"Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems","volume":"3","author":"Moltke","year":"2021","journal-title":"J Cannabis Res"},{"key":"R7-20260304","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/molecules29020473","article-title":"An overview of cannabidiol as a multifunctional drug: pharmacokinetics and cellular effects","volume":"29","author":"Martinez Naya","year":"2024","journal-title":"Molecules"},{"key":"R8-20260304","doi-asserted-by":"crossref","first-page":"8825358","DOI":"10.1155\/2023\/8825358","article-title":"Emerging therapeutic potential of cannabidiol (CBD) in neurological disorders: a comprehensive review","volume":"2023","author":"Singh","year":"2023","journal-title":"Behav Neurol"},{"key":"R9-20260304","doi-asserted-by":"crossref","first-page":"300\u201305","DOI":"10.1007\/s13312-025-00015-7","article-title":"Cannabinoid use in pediatric epilepsy","volume":"62","author":"Whitney","year":"2025","journal-title":"Indian Pediatr"},{"key":"R10-20260304","first-page":"463\u201377","article-title":"Use of cannabidiol (CBD) for the treatment of chronic pain","volume":"34","author":"Urits","year":"2020","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"R11-20260304","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11910-018-0882-y","article-title":"Cannabis for the treatment of epilepsy: an update","volume":"18","author":"Gaston","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R12-20260304","first-page":"724\u201352","article-title":"Cannabidiol-associated hepatotoxicity: a systematic review and meta-analysis","volume":"293","author":"Lo","year":"2023","journal-title":"J Intern Med"},{"key":"R13-20260304","doi-asserted-by":"crossref","first-page":"1799\u2013806","DOI":"10.1038\/s41386-020-0667-2","article-title":"Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials","volume":"45","author":"Chesney","year":"2020","journal-title":"Neuropsychopharmacol"},{"key":"R14-20260304","doi-asserted-by":"crossref","first-page":"517\u201326","DOI":"10.1080\/17425255.2020.1754793","article-title":"Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials","volume":"16","author":"Dos Santos","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R15-20260304","doi-asserted-by":"crossref","first-page":"1224\u201331","DOI":"10.1002\/cpt.2071","article-title":"Cannabidiol and abnormal liver chemistries in healthy adults: results of a phase I clinical trial","volume":"109","author":"Watkins","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"R16-20260304","doi-asserted-by":"crossref","first-page":"1888\u201397","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the Lennox\u2013Gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med"},{"key":"R17-20260304","doi-asserted-by":"crossref","first-page":"2522\u201332","DOI":"10.1111\/jgh.16730","article-title":"Clinical guidance for cannabidiol-associated hepatotoxicity: a narrative review","volume":"39","author":"Eadie","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"key":"R18-20260304","first-page":"100082","article-title":"Transparent Integration of Technology and Artificial Intelligence in Academic Narratives (TITAN) Guidelines 2025: principles for AI-Assisted Scientific Writing","volume":"77","year":"2025","journal-title":"Pak J Sci"},{"key":"R19-20260304","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R20-20260304","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12874-024-02356-6","article-title":"Meta-analysis accelerator: a comprehensive tool for statistical data conversion in systematic reviews with meta-analysis","volume":"24","author":"Abbas","year":"2024","journal-title":"BMC Med Res Methodol"},{"key":"R21-20260304","first-page":"1\u201314","article-title":"The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: a randomised controlled trial","author":"Sultan","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"R22-20260304","doi-asserted-by":"crossref","first-page":"575\u201386","DOI":"10.1007\/s13318-020-00624-6","article-title":"A Phase 1, randomised, placebo-controlled, dose escalation study to investigate the safety, tolerability and pharmacokinetics of cannabidiol in fed healthy volunteers","volume":"45","author":"Perkins","year":"2020","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"R23-20260304","doi-asserted-by":"crossref","first-page":"1053\u201367","DOI":"10.1007\/s40263-018-0578-5","article-title":"A Phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"key":"R24-20260304","article-title":"Cannabidiol and liver enzyme level elevations in healthy adults: a randomized clinical trial","author":"Florian","journal-title":"JAMA Intern Med"},{"key":"R25-20260304","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R26-20260304","doi-asserted-by":"crossref","first-page":"741\u201353","DOI":"10.1136\/jnnp-2017-317168","article-title":"Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence","volume":"89","author":"Stockings","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R28-20260304","first-page":"e26913","article-title":"Efficacy, safety, and regulation of cannabidiol on chronic pain: a systematic review","volume":"14","author":"Villanueva","year":"2022","journal-title":"Cureus"},{"key":"R29-20260304","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.pmn.2023.10.002","article-title":"Effectiveness of cannabidiol to manage chronic pain: a systematic review","volume":"25","author":"Mohammed","year":"2024","journal-title":"Pain Manage Nurs"},{"key":"R30-20260304","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2174\/1570159X17666190603171901","article-title":"Cannabidiol adverse effects and toxicity","volume":"17","author":"Huestis","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"R31-20260304","doi-asserted-by":"crossref","first-page":"101972","DOI":"10.1016\/j.cdnut.2023.101972","article-title":"Cannabidiol and intestinal motility: a systematic review","volume":"7","author":"Story","year":"2023","journal-title":"Curr Dev Nutr"},{"key":"R32-20260304","doi-asserted-by":"crossref","first-page":"139\u201354","DOI":"10.1089\/can.2016.0034","article-title":"An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"R33-20260304","doi-asserted-by":"crossref","first-page":"10\u201318","DOI":"10.1016\/j.ejim.2021.05.002","article-title":"\u201cIs medical cannabis safe for my patients?\u201d A practical review of cannabis safety considerations","volume":"89","author":"MacCallum","year":"2021","journal-title":"Eur J Intern Med"},{"key":"R34-20260304","doi-asserted-by":"crossref","DOI":"10.1186\/s42238-021-00078-w","article-title":"Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic","volume":"3","author":"Rapin","year":"2021","journal-title":"J Cannabis Res"},{"key":"R37-20260304","doi-asserted-by":"crossref","first-page":"135\u201361","DOI":"10.1353\/pbm.1968.0004","article-title":"The spectrum of hepatotoxicity","volume":"12","author":"Zimmerman","year":"1968","journal-title":"Perspect Biol Med"},{"key":"R38-20260304","first-page":"950\u201366","article-title":"ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury","volume":"109","author":"Chalasani","year":"2014","journal-title":"Ame J Gastroenterol"},{"key":"R39-20260304","doi-asserted-by":"crossref","first-page":"1085\u201396","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"R40-20260304","first-page":"270\u201378","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol"},{"key":"R41-20260304","doi-asserted-by":"crossref","first-page":"1617\u201324","DOI":"10.1111\/epi.13499","article-title":"Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex","volume":"57","author":"Hess","year":"2016","journal-title":"Epilepsia"},{"key":"R42-20260304","doi-asserted-by":"crossref","first-page":"859\u201367","DOI":"10.1136\/gut.48.6.859","article-title":"Cannabinoids and the gastrointestinal tract","volume":"48","author":"Pertwee","year":"2001","journal-title":"Gut"},{"key":"R43-20260304","doi-asserted-by":"crossref","DOI":"10.3389\/adar.2022.10550","article-title":"Role of Gut Microbiota in Cannabinoid-Mediated Suppression of Inflammation","volume":"2","author":"Varsha","year":"2022","journal-title":"Adv Drug Alcohol Res"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000004549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:01:18Z","timestamp":1772622078000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000004549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000004549","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"2025-11-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}